Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 43,258 | 32,325 | 21,180 | 16,756 | 7,467 |
| Cost of Goods | 11,810 | 13,144 | 13,167 | 10,063 | 5,127 |
| Gross Profit | 31,448 | 19,181 | 8,013 | 6,693 | 2,340 |
| Operating Expenses | 94,767 | 82,372 | 66,820 | 68,525 | 46,598 |
| Operating Income | -63,319 | -63,191 | -58,807 | -61,832 | -44,258 |
| Interest Expense | N/A | 43 | 57 | 11 | 22 |
| Other Income | 18,855 | -856 | 1,539 | -46 | -4,838 |
| Pre-tax Income | -44,464 | -64,090 | -57,325 | -61,889 | -49,118 |
| Income Tax | 845 | -8,972 | -8,325 | -8,700 | -4,762 |
| Net Income Continuous | -45,309 | -55,118 | -49,000 | -53,189 | -44,356 |
| Net Income | $-45,309 | $-55,118 | $-49,000 | $-53,189 | $-44,356 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | -0.40 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | -0.40 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | -0.40 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | -0.40 |
| EBITDA(a) | $-62,726 | $-63,412 | $-56,685 | $-61,302 | $-48,420 |